IRCT138902033777N1
Completed
Phase 2
Improvement of oxidative stress injuries following the supplementation of zinc in chronic hemodialysis patients
Drug Applied Research Center-Tabriz University of Medical Sciences0 sites73 target enrollmentTBD
Conditionspatients with hemodialsis.Acute nephritic syndrome, Rapidly progressive nephritic syndrome, Chronic nephritic syndrome, Nephrotic syndrome, Unspecified nephritic syndrome, Glomerular disorders in diseases classified elsewhere, Acute renal failure, Chronic renal failure, UnspecifieN00, N01,N
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- patients with hemodialsis.
- Sponsor
- Drug Applied Research Center-Tabriz University of Medical Sciences
- Enrollment
- 73
- Status
- Completed
- Last Updated
- 8 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Hemodialysis more than 6 month, Age more than 20 year, referring to Tabriz Sina Hospital for hemodialysis
- •Exclusion criteria: presence of gastrointestinal disorders, smoking, kidney transplantation candidates, lactation, pregnancy, consumption of glucocorticoids, antibiotics, penicilamine, estrogens or contraceptives (in females), hospitalization due to other reasons than chronic renal failure
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
Effect of antioxidants in healing after gum surgeryHealth Condition 1: K053- Chronic periodontitisCTRI/2019/04/018463Thaslim Fathima
Not yet recruiting
Phase 1
Effect of Anti-Oxident therapy for post-operative vocal fold surgery: A clinical trialJPRN-jRCTs051220033Hirano Shigeru20
Active, not recruiting
Phase 1
Preventing Systemic Inflammation after Cardiac surgery with Alkaline Phosphatase (APPIRED III)systemic inflammation as side-effect of heart-lung machine during cardiac surgeryMedDRA version: 20.0 Level: LLT Classification code 10017501 Term: Functional disturbances following cardiac surgery System Organ Class: 100000004863Therapeutic area: Body processes [G] - Immune system processes [G12]EUCTR2016-002663-33-BEAlloksys Life Sciences BV1,250
Recruiting
Phase 3
Preventing Oxidative stress-induced ischemic injury and systemic inflammation complications during and after invasive cardiac surgery with Alkaline Phosphatase (APPIRED III)NL-OMON49105Alloksys Life Sciences BV150
Active, not recruiting
Phase 1
Preventing Systemic Inflammation after Cardiac surgery by Alkaline Phosphatase (APPIRED III)systemic inflammation as side-effect of heart-lung machine during cardiac surgeryMedDRA version: 20.0 Level: LLT Classification code 10017501 Term: Functional disturbances following cardiac surgery System Organ Class: 100000004863MedDRA version: 20.0 Level: LLT Classification code 10062357 Term: SIRS System Organ Class: 100000004867Therapeutic area: Body processes [G] - Immune system processes [G12]EUCTR2016-002663-33-NLAlloksys Life Sciences BV1,250